Caribou Biosciences, Inc. (CRBU)
0.4487
+0.04
(+8.83%)
USD |
NASDAQ |
Nov 06, 16:00
0.4423
-0.01
(-1.43%)
After-Hours: 20:00
Caribou Biosciences Total Long Term Debt (Quarterly) : 24.88M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 24.88M |
| June 30, 2026 | 25.28M |
| March 31, 2026 | 25.66M |
| December 31, 2025 | 26.03M |
| September 30, 2025 | 22.78M |
| June 30, 2025 | 23.56M |
| March 31, 2025 | 24.32M |
| December 31, 2024 | 25.06M |
| September 30, 2024 | 25.46M |
| June 30, 2024 | 25.53M |
| March 31, 2024 | 25.90M |
| December 31, 2023 | 25.91M |
| September 30, 2023 | 26.32M |
| June 30, 2023 | 26.16M |
| Date | Value |
|---|---|
| March 31, 2023 | 26.40M |
| December 31, 2022 | 26.78M |
| September 30, 2022 | 26.96M |
| June 30, 2022 | 27.09M |
| March 31, 2022 | 27.24M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 150.15M |
| March 31, 2021 | 151.73M |
| December 31, 2020 | 42.90M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | 0.00 |
| Vaxcyte, Inc. | 215.14M |
| Foghorn Therapeutics, Inc. | 40.28M |
| Bolt Biotherapeutics, Inc. | 18.53M |
| Connect Biopharma Holdings Ltd. | 0.203M |